[1]王小林,谷亚男,陈伟,等.中医中药为胰腺癌介入治疗赋能2例报告[J].介入放射学杂志,2025,34(03):321-323.
 WANG Xiaolin,GU Yanan,CHEN Wei,et al.Traditional Chinese medicine enhancing the efficacy of interventional therapy for pancreatic cancer:report of two cases[J].journal interventional radiology,2025,34(03):321-323.
点击复制

中医中药为胰腺癌介入治疗赋能2例报告()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
34
期数:
2025年03
页码:
321-323
栏目:
病例报告
出版日期:
2025-03-25

文章信息/Info

Title:
Traditional Chinese medicine enhancing the efficacy of interventional therapy for pancreatic cancer:report of two cases
作者:
王小林谷亚男陈伟雷洋洋李建柯高珊珊蔡定芳
Author(s):
WANG XiaolinGU YananCHEN WeiLEI YangyangLI JiankeGAO ShanshanCAI Dingfang
Department of Interventional Radiology,Affiliated Zhongshan Hospital of Fudan University,Shanghai 200030,China
关键词:
【关键词】胰腺癌中医药介入治疗
文献标志码:
A

参考文献/References:

[1] Awaji M,Singh RK.Cancer-Associated Fibroblasts′ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma[J].Cancers (Basel),2019,11:290.
[2]Stoffel EM,Brand RE,Goggins M.Pancreatic cancer:changing epidemiology and new approaches to risk assessment,early detection,and prevention[J].Gastroenterology,2023,164:752-765.
[3]Halbrook CJ,Lyssiotis CA,Pasca di Magliano M,et al.Pancreatic cancer:Advances and challenges[J].Cell,2023,186:1729-1754.
[4]Siegel RL,Giaquinto AN,Jemal A.Cancer statistics,2024[J].CA Cancer J Clin,2024,74:12-49.
[5]Su XL,Wang JW,Che H,et al.Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer[J].Chin Med J (Engl),2020,133:2987-2997.
[6]Chen JF,Wu SW,Shi ZM,et al.Traditional Chinese medicine for colorectal cancer treatment:potential targets and mechanisms of action[J].Chin Med,2023,18:14.
[7]Li Z,Feiyue Z,Gaofeng L.Traditional Chinese medicine and lung cancer:from theory to practice[J].Biomed Pharmacother,2021,137:111381.
[8]Gao Y,Chen SY,Sun JY,et al.Traditional Chinese medicine May be further explored as candidate drugs for pancreatic cancer:a review[J].Phytother Res,2021,35:603-628.
[9]王丽娟,路军章.中医药治疗胰腺癌的研究进展[J].中华中医药杂志,2016,31:961-964.
[10]王小林,雷洋洋,李建柯,等.基于荷瘤小鼠模型及生物信息学探讨燥湿解毒复方对胰腺癌的影响[J].复旦学报(医学版),2022,49:916-923.
[11]花永强,刘鲁明,陈震,等.胰腺癌中医证治理论体系的现代认识[J].中国中西医结合杂志,2019,39:107-110.
[12]张传龙,刘福栋,姜晓晨,等.基于“辨病论治”五步探讨胰腺癌前病变辨治思路[J].世界中医药,2024,19:687-690.

相似文献/References:

[1]周诚,沈天皓,蒋霆辉,等.125I粒子联合动脉灌注化疗对中晚期胰腺癌患者的临床疗效观察 [J].介入放射学杂志,2024,33(08):878.
 ZHOU Cheng,SHEN Tianhao,JIANG Tinghui,et al.Clinical effect of 125I seeds implantation combined with arterial infusion chemotherapy for patients with advanced pancreatic cancer[J].journal interventional radiology,2024,33(03):878.
[2]张云晓,孙振海,张梦贺,等.基于引文空间的中医药治疗经皮冠状动脉介入术后患者的可视化分析[J].介入放射学杂志,2024,33(10):1064.
 ZHANG Yunxiao,SUN Zhenhai,ZHANG Menghe,et al.CiteSpace-based visualization analysis of traditional Chinese medicine treatment for patients after receiving percutaneous coronary intervention[J].journal interventional radiology,2024,33(03):1064.

备注/Memo

备注/Memo:
(收稿日期:2024-08-17)
(本文编辑:谷珂)
更新日期/Last Update: 2025-03-25